Brinker Capital Inc. purchased a new stake in shares of InVitae Corp (NYSE:NVTA) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The insti

InVitae (NYSE:NVTA) Stock Price Up 1.2%

06:52am, Sunday, 05'th Apr 2020
InVitae Corp (NYSE:NVTA)’s stock price rose 1.2% during mid-day trading on Friday . The stock traded as high as $13.25 and last traded at $12.80, approximately 155,268 shares traded hands during mid
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics
InVitae Corp (NYSE:NVTA) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totalling 22,133,500 shares, an increase of 7.

Here's Why Invitae Stock Is Swinging Wildly Today

05:54pm, Thursday, 02'nd Apr 2020
The company announced the pricing of a public offering of common stock.
Fly Intel: Pre-market Movers DAL AAL JBLU LUV ALK SAVE UAL ARNC WBA KMX PVH DYNT CCL ZM NVTA

LK, CCL among premarket losers

01:16pm, Thursday, 02'nd Apr 2020
Luckin Coffee (NASDAQ:LK) -84% on fraud finding.Golar LNG Partners (NASDAQ:GMLP) -55% on dividend cut.Safe-T Group (NASDAQ:SFET) -28% after pricing direct offering.Dynatronics (NASDAQ:DYNT) -22%�

IFR US ECM Calendar

12:36pm, Thursday, 02'nd Apr 2020
NEW YORK, April 2 (IFR) -
Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's
Pre-open movers U.S. stock futures traded higher in early pre-market trade. The Challenger job-cut report for March is scheduled for release at 7:30 a.m. ET. Data on international...

5 Stocks To Watch For April 2, 2020

09:10am, Thursday, 02'nd Apr 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Walgreens Boots Alliance Inc (NASDAQ: WBA) to report quarterly earnings at $1.46 per share on...
Stoke Therapeutics (NASDAQ: STOK) is one of 606 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Stoke Thera
Stoke Therapeutics (NASDAQ:STOK) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Thursday, ValuEngine reports. Several other eq
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE